Cell Biotech Co., Ltd. (KOSDAQ:049960)

Cell Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	117,784	89,724	97,662	76,789	86,918	133,300
Market Cap Growth	32.79%	-8.13%	27.18%	-11.65%	-34.80%	-19.84%
Enterprise Value	25,147	1,343	19,190	10,612	22,959	70,193
Last Close Price	17210.00	13110.00	13643.66	10388.77	11289.59	16183.18
PE Ratio	11.64	8.86	6.46	12.18	10.50	12.84
Forward PE	-	8.16	8.16	8.16	8.16	8.16
PS Ratio	2.22	1.69	1.96	1.43	1.72	2.84
PB Ratio	0.89	0.68	0.79	0.69	0.80	1.25
P/TBV Ratio	0.90	0.69	0.80	0.70	0.82	1.27
P/FCF Ratio	14.71	11.21	5.38	12.26	8.32	9.49
P/OCF Ratio	10.60	8.08	5.07	9.82	6.78	8.95
EV/Sales Ratio	0.47	0.03	0.38	0.20	0.45	1.50
EV/EBITDA Ratio	2.18	0.12	1.80	1.74	2.37	6.36
EV/EBIT Ratio	3.18	0.17	2.82	4.83	3.79	9.67
EV/FCF Ratio	3.14	0.17	1.06	1.69	2.20	5.00
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.04	0.04	0.10	0.25	0.10	0.07
Debt / FCF Ratio	0.05	0.05	0.06	0.25	0.09	0.06
Net Debt / Equity Ratio	-0.70	-0.70	-0.70	-0.61	-0.60	-0.53
Net Debt / EBITDA Ratio	-8.04	-8.04	-8.10	-11.28	-6.65	-5.16
Net Debt / FCF Ratio	-11.57	-11.57	-4.76	-10.98	-6.17	-4.06
Asset Turnover	0.40	0.40	0.40	0.46	0.44	0.43
Inventory Turnover	3.35	3.35	3.39	3.68	3.34	3.21
Quick Ratio	20.19	20.19	15.71	15.74	9.54	10.89
Current Ratio	21.34	21.34	16.57	16.99	10.24	11.71
Return on Equity (ROE)	7.92%	7.92%	12.82%	5.73%	7.71%	10.05%
Return on Assets (ROA)	3.71%	3.71%	3.43%	1.18%	3.31%	4.16%
Return on Invested Capital (ROIC)	18.32%	18.56%	16.29%	4.63%	10.55%	12.97%
Return on Capital Employed (ROCE)	6.00%	6.00%	5.50%	1.90%	5.60%	6.80%
Earnings Yield	8.60%	11.29%	15.49%	8.21%	9.53%	7.79%
FCF Yield	6.80%	8.92%	18.57%	8.16%	12.02%	10.54%
Dividend Yield	3.49%	-	-	4.33%	3.99%	2.78%
Payout Ratio	30.42%	30.42%	20.36%	48.86%	38.43%	30.65%
Buyback Yield / Dilution	-0.02%	-0.02%	-0.01%	0.73%	2.50%	0.32%
Total Shareholder Return	3.47%	-0.02%	-0.01%	5.07%	6.49%	3.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.